Gender: Male
Clinical Interest for Patients: Structural heart disease interventions encompassing a wide array of catheter-based valvular (e.g. transcatheter aortic valve replacement [TAVR]) and non-valvular (i.e., closure of "holes in the heart" and other cardiovascular defects) / Advanced coronary interventions
Care Philosophy: "My goal is to provide patients with comprehensive cardiovascular care and emphasize a strong patient-physician relationship, both in the acute setting and in the setting of clinic-based continuous care."
Personal Interests: Golfing, biking, skiing and spending time with his wife and family.

Website
http://www.ncbi.nlm.nih.gov/pubmed?term="Kim MS"[Author]

Research Interests
Dr. Kim is an investigator for the PARTNER II Trial, which is studying transcatheter aortic valve replacement (TAVR) with the Edwards Sapien XT Transcatheter Heart Valve, a minimally invasive option for patients with severe aortic stenosis. He is also an investigator for the COAPT Trial, which is studying the Mitraclip Mitral Valve Repair System for patients with functional mitral regurgitation. Dr. Kim is also interested in the integration of advanced imaging modalities in the cardiac catheterization laboratory, investigation of new implantable cardiac devices, and novel approaches to medical education and training, specifically in the realm of structural heart disease interventions.

Clinical Interests for Referring Providers: Structural heart disease interventions (transcatheter aortic valve replacement [TAVR], transcatheter pulmonary valve replacement, transcatheter MV repair, valvuloplasty, percutaneous PFO/ASD/VSD/paravalvular leak closure, LAA occlusion, transcatheter pseudoaneurysm repair, etc.) / Advanced coronary interventions

Research Interest for Referring Providers: Dr. Kim is an investigator for the PARTNER II Trial, which is studying transcatheter aortic valve replacement (TAVR) with the Edwards Sapien XT Transcatheter Heart Valve, a minimally invasive option for patients with severe aortic stenosis. He is also an investigator for the COAPT Trial, which is studying the Mitraclip Mitral Valve Repair System for patients with functional mitral regurgitation. Dr. Kim is also interested in the integration of advanced imaging modalities in the cardiac catheterization laboratory, investigation of new implantable cardiac devices, and novel approaches to medical education and training, specifically in the realm of structural heart disease interventions.